Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Contacted members of the Senate to seek support for S1066, The Economic Development Act of 2005. The bill would give states the right to use tax incentives to enhance economic development within their borders.
Contacted members of the House and Senate to encourage their opposition to S2300/HR6200, a bill which would require an abbreviated application for a new drug containing certain antibiotics where patent infringement cases are involved.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
KING PHARMACEUTICALS INC via D. LYNN JOHNSON
2007 · year_end · YT
Asked members of the Senate and House to request that FDA enforce the laws and rules regarding the approval and promotion of thrombin products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KING PHARMACEUTICALS INC via D. LYNN JOHNSON
2007 · mid_year · MM
Source: Senate LDA
Contacted a member of the House to ask support for an appropriation to procure and install emergency FDA approved self administered auto-injectors containing atropine and prolidoxime in the Washington Transit Authority Metro Rail System.
Contacted members of the House and Senate to express concern for an FAA proposal to hike taxes and User Fees on General Aviation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KING PHARMACEUTICALS INC via D. LYNN JOHNSON
2006 · year_end · YY
Contacted members of the Senate to seek support for S1066, The Economic Development Act of 2005. The bill would give states the right to use tax incentives to enhance economic development within their borders.
Contacted members of the House and Senate to encourage their opposition to S2300/HR6200, a bill which would require an abbreviated application for a new drug containing certain antibiotics where patent infringement cases are involved.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KING PHARMACEUTICALS INC via D. LYNN JOHNSON
2005 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KING PHARMACEUTICALS INC via D. LYNN JOHNSON
2005 · year_end · YY
Contacted members of the U.S. House and U.S. Senate to ask support for an appropriation to procure and install emergency FDA approved self administered auto-injectors containing atropine and prolidoxime in the Washington Metropolitan Area Transit Authority Metro Rail System.
Contacted members of the House and Senate to make them aware of King's concern about the Importation/Reimportation of drugs into the United States.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KING PHARMACEUTICALS INC via D. LYNN JOHNSON
2004 · year_end · YY
Contacted a member of the US House to ask support for an appropriation to procure and install emergency FDA approved self-administered auto-injectors containing atropine and pralidoxime in the Washington Metropolitan Area Transit Authority Metro Rail System.
Contacted members of the House and Senate to make them aware of King's concern about the importation/reimportation of drugs into the United States.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KING PHARMACEUTICALS INC via D. LYNN JOHNSON
2004 · year_end · YA
Contacted members of the House and Senate to make them aware of King's concern about the importation/reimportation of drugs into the United States.
Asked a Senate Office to obtain information from the FDA regarding interim progress made towards approving or disapproving and ANDA for levothyroxine sodium tablets.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KING PHARMACEUTICALS INC via D. LYNN JOHNSON
2004 · mid_year · MM
Contacted a member of the U.S. House to ask support for an appropriation to procure and install emergency FDA approved self-administered auto-injectors containing atropine and pralidoxime in the Washington Metropolitan Area Transit Authority Metro Rail System.
Contacted members of the House and Senate to make them aware of King's concern about the importation/reimportation of drugs into the United States.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KING PHARMACEUTICALS INC via D. LYNN JOHNSON
2003 · mid_year · MM
Filing targets: SENATE
KING PHARMACEUTICALS INC via D. LYNN JOHNSON
2003 · mid_year · RR